UTAH MEDICAL PRODUCTS, INC. (UTMD) Debt Components
- 2026-06-30: Long-term Debt and Lease ObligationUSD $195.00K; Long-term DebtUSD (m); Notes Payable, CurrentUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2026-03-31: Long-term Debt and Lease ObligationUSD $210.00K; Long-term DebtUSD (m); Notes Payable, CurrentUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt and Lease ObligationUSD $225.00K; Long-term DebtUSD (m); Notes Payable, CurrentUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt and Lease ObligationUSD (m); Long-term DebtUSD $0.00; Notes Payable, CurrentUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
UTAH MEDICAL PRODUCTS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt and Lease Obligation USD | Long-term Debt USD | Notes Payable, Current USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $195.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $210.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $225.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $269.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $282.00K | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $295.00K | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $1.01K | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | $3.89M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $5.07K | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | $4.00M | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | $4.14M | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | $4.07M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | $4.05M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | $4.05K | $4.05K | $1.01K | (m) |
| 2013-12-31 | (m) | $9.00K | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | $3.99M | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | $3.83M | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | $3.83M | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $4.00M | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | $4.00K | $4.00K | $4.00K | $1.00K |
| 2012-09-30 | (m) | (m) | $5.45M | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | $5.41M | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | $5.49M | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | $5.43M | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | $5.47M | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | $5.57M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $215.00K | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |